I do not believe in good or bad stocks, only in good or bad prices for them. I am not afraid of volatility, and if I believe in a stock's prospects I will chase it all the way down to pennies. I am a patient investor, and if I like a company I will generally commit for the long haul. I rarely go short - the potential benefits in my view rarely compensate for the risks incurred. I sometimes use leverage, but in a disciplined way. Leverage and emotions don't mix. I always look at the math, numbers, and accounting behind any investment target or strategy. I believe that in finance the devil is in the details, and that most of the "macro outlook" commentary that pervades the financial media and financial forums is uninformed, pretentious mumbo-jumbo. I invest in many industrial sectors: energy (mainly oil & gas), mining, transportation, banking, and real estate. I do however shy away from segments of the market that I do not understand (e.g., biotechnology).
I do not render individualized investment advice, and I do not manage or solicit for management any third-party capital. My analyses are solely for informational/educational purposes, and may contain errors.
Dmitry Demidenko is an expert in the area of fundamental analysis of the currency and commodity markets. He is among the TOP-5 analysts from Russia's first independent analytical agency Investcafe. He has an industry-specific economics education, with a degree in finance. Dmitry has been a FOREX trader since 2004 and has served as an analyst and asset manager since 2010.
I am an individual investor. My professional background is in the finance area. I have managed my own investments for over 30 years. For most of that time, my focus was on portfolio building using individual stocks. About 5 years ago, I shifted my focus to investing via ETFs. I have found that this has greatly simplified my investment style yet simultaneously increased the scope and diversification of my portfolio.
I firmly believe that the benefits of investing, and the market, should be understandable and available to everyone, including individuals who may have little or no financial background. My hope is to explain concepts simply, taking much of the mystery and accompanying fear out of the process. I look forward to enjoying the journey with everyone who decides to follow me, and hope I can make a difference in someone's life.
In addition to my blog, you can find me at:
EP Vantage is a forward-looking comment and analysis service tailored to the needs of pharma and finance professionals, focusing on the events that will define the future of companies, products and therapy areas. Written by experienced journalists, EP Vantage provides timely financial analysis of regulatory and patent decisions, marketing approvals, licensing deals, and M&A, giving fresh angles and insight to both current and future industry triggers. EP Vantage is powered by EvaluatePharma, the industry leader in consensus forecasts.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Background in corporate finance at multiple Fortune 200 companies including real-estate, media, and banking. Believe strongly in detailed analysis of company balance sheets and income statements, going into deeper detail than the average investor. Look to identify companies whose fundamental financials or outlook, differ significantly the the market value afforded to that company at a particular point in time. As a rule, beginning May 2013, I very rarely will hold any position in a stock that I cover on Seeking Alpha. This is done solely to protect the integrity of my research and opinion expressed in any article contributed to the site. In the rare case that I do hold a position in a stock I discuss, it will be clearly noted in the customary disclosure as well as the article itself.